Mitsubishi Tanabe Pharma Corp. Newsletter
-
New ANDA Cases - Fourth Quarter 2025
03 Feb 2026 23:53 GMT
… 037,644
10,478,494
Mitsubishi Tanabe Pharma Corp. v. Sandoz Inc … 285,409
12,310,946
Mitsubishi Tanabe Pharma Corp. v. Shanghai … 194,025
12,310,946
Mitsubishi Tanabe Pharma Corp. v. Apotex Inc … ,940,128
11,020,363
Mitsubishi Tanabe Pharma Corp. v. Zydus Pharms …
-
Endometriosis Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
22 Jan 2026 18:00 GMT
… new endometriosis treatments, visit @ Endometriosis Drugs Table of Contents
1.
Endometriosis … key endometriosis companies, including Mitsubishi Tanabe Pharma America, Ferring Pharmaceuticals, AbbVie, Neurocrine Biosciences, ObsEva …
-
Buyout wave seen among Japan drugmakers after Hisamitsu deal
08 Jan 2026 02:56 GMT
… markets among Japan’s drugmakers, with analysts expecting … -forced price cuts, drugmakers are opting to delist … two years, Mitsubishi Tanabe Pharma and Taisho Pharmaceutical Holdings have also … Investments has urged Aska Pharmaceutical Holdings to consider …
-
Amyotrophic Lateral Sclerosis Market Outlook: Expanding Therapeutic Pipeline and Novel Drug Launches Propel Growth Throughout Forecast Period (2025-2034) | DelveInsight
09 Dec 2025 23:26 GMT
… ORS (EDARAVONE ORAL): MITSUBISHI TANABE PHARMA CORPORATION
13
Emerging ALS Drugs
13.1
Key Competitors … , Novartis, Annovis Bio, Supernus Pharmaceuticals, Inc., Britannia Pharmaceutical, Pharma Two B, Mitsubishi Tanabe Pharma (NeuroDerm), AbbVie, Cerevel …
-
Mitsubishi Tanabe Pharma America to Present New Data on Investigational ND0612 at the 2025 International Congress of Parkinson's Disease and Movement Disorders®
03 Oct 2025 13:43 GMT
… Twitter), Facebook and LinkedIn.
About Mitsubishi Tanabe Pharma Corporation
Mitsubishi Tanabe Pharma Corporation (MTPC) is one … ;precision medicine" to provide drugs with high treatment satisfaction and …
-
Tanabe Pharma shifts gears for Bain-backed future, dropping Mitsubishi moniker after $3.3B deal
02 Dec 2025 03:12 GMT
Mitsubishi Tanabe Pharma has undergone a rebrand. … deal to buy the Japanese drugmaker from its parent company, … forward, the Japanese drugmaker will operate as Tanabe Pharma. The new … the modern drugmaker when it merged with Mitsubishi Pharma in 2001 …
-
Generic Musculoskeletal Disorders Drugs Market to Reach USD $0.08 Billion by 2029 at 6.9% CAGR
24 Nov 2025 10:45 GMT
… market prominence. For instance, Mitsubishi Tanabe Pharma Corporation, a pharmaceutical firm based in Japan … ) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Drug Store, Online Pharmacy
Subsegments:
1) By …
-
Sanofi Korea transfers MS drug Aubagio rights to Mitsubishi Tanabe
15 Sep 2025 09:46 GMT
Sanofi Korea has granted Mitsubishi Tanabe Pharma Korea exclusive rights to market … arrangement, effective Sept. 1, gives Mitsubishi Tanabe control of sales and marketing …
-
FDA Grants Orphan Drug Designation to Dewpoint Therapeutics’ DPTX3186 for the Treatment of Gastric Cancer
29 Oct 2025 14:00 GMT
… art integrated technology underlies a drug discovery pipeline that spans … with Bayer, Novo Nordisk, and Mitsubishi Tanabe Pharma Corporation, Dewpoint pushes the boundaries … and neurological disorders. Condensate-modulating drugs (c-mods) potentially provide …
-
Dewpoint receives FDA orphan drug designation for DPTX3186
30 Oct 2025 12:51 GMT
… recently opened its investigational new drug application for the oral … review processes.
Dewpoint’s drug discovery pipeline encompasses several therapeutic … company operates through partnerships with Mitsubishi Tanabe Pharma, Bayer and Novo Nordisk.
…
About
© 1995-2026